1. Arndts D, Doevendans J, Kirsten R, Heintz B: New Aspects of the Pharmacokinetics and Pharmacodynamics of Clonidine in Man. Europ J Clin Pharmacol, in press.
2. Bock KD, Merguet P, Heimsoth VH: Effect of Clonidine on regional blood flow and its use in the treatment of hypertension. In: 26th Hahnemann Symposium: Hypertension Mechanisms and Management, G Onesti, KE Kim, JH Moyer, New York, Grune & Stratton, 1973, pp 395–403.
3. Brodde O-E, Anlauf M, Graben N und Bock KD: In vitro and in vivo down-regulation of human platelet a
2
-adrenoceptors by Clonidine. Europ J Clin Pharmacol 23:403–409 (1982 b).
4. Brodde O-E, Daul A und Graben N: Decreased number of α
2-adrenergic receptors in platelets of patients on maintenance hemodialysis. Proc Europ Dialysis Transplant Assoc 19:270–274 (1982c).
5. Davies DS, Wing LMH, Reid JL, Neill E, Tippett P, Dollery CT: Pharmacokinetics and concentration-effect relationships of intravenous and oral Clonidine. Clin Pharmacol Ther 21:593–601(1977).